This Clinical Industrial partnership does not result in any immediate revenue lines for OSX, I will add this as part of R&D. While the company might have some niche products, I doubt the business acumen of those who run the company. To let the stock slide to its present level without evoking any response from the management shows lack of intent and sensitivity to shareholder interest.
- Forums
- ASX - By Stock
- OSX
- Ann: Osteopore secures A$19m clinical-industrial partnership
Ann: Osteopore secures A$19m clinical-industrial partnership, page-5
Featured News
Add OSX (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $6.645M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.7¢ | $11.56K | 201.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 484833 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 114673 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 484833 | 0.056 |
6 | 226362 | 0.055 |
2 | 212000 | 0.054 |
1 | 14000 | 0.053 |
2 | 157690 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 114673 | 2 |
0.060 | 16500 | 1 |
0.061 | 34628 | 2 |
0.062 | 28924 | 2 |
0.063 | 27750 | 2 |
Last trade - 13.19pm 28/06/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online